These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 11139877
1. [Post-parotidectomy Frey's syndrome. Treatment with botulinum toxin type A]. Cavalot AL, Palonta F, Preti G, Nazionale G, Ricci E, Staffieri A, Di Girolamo S, Cortesina G. Acta Otorhinolaryngol Ital; 2000 Jun; 20(3):187-91. PubMed ID: 11139877 [Abstract] [Full Text] [Related]
3. Treatment of Frey's syndrome with botulinum toxin. Pomprasit M, Chintrakarn C. J Med Assoc Thai; 2007 Nov; 90(11):2397-402. PubMed ID: 18181326 [Abstract] [Full Text] [Related]
4. Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A. Eckardt A, Kuettner C. Head Neck; 2003 Aug; 25(8):624-8. PubMed ID: 12884344 [Abstract] [Full Text] [Related]
5. Botulinum toxin A for quality of life improvement in post-parotidectomy gustatory sweating (Frey's syndrome). Hartl DM, Julieron M, LeRidant AM, Janot F, Marandas P, Travagli JP. J Laryngol Otol; 2008 Oct; 122(10):1100-4. PubMed ID: 18289458 [Abstract] [Full Text] [Related]
6. [Treatment of Frey's syndrome with botulinum A toxin]. Braunius WW, Gerrits MA. Ned Tijdschr Geneeskd; 1998 Apr 11; 142(15):859-63. PubMed ID: 9623161 [Abstract] [Full Text] [Related]
7. The use of botulinum toxin in Frey's Syndrome. Khoo SG, Keogh IJ, Timon C. Ir Med J; 2006 May 11; 99(5):136-7. PubMed ID: 16892916 [Abstract] [Full Text] [Related]
10. Increased botulinum toxin type A dosage is more effective in patients with Frey's syndrome. Guntinas-Lichius O. Laryngoscope; 2002 Apr 11; 112(4):746-9. PubMed ID: 12150533 [Abstract] [Full Text] [Related]
12. Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operations. Guntinas-Lichius O, Gabriel B, Klussmann JP. Acta Otolaryngol; 2006 Oct 11; 126(10):1104-9. PubMed ID: 16923718 [Abstract] [Full Text] [Related]
13. Control of Frey's syndrome in patients treated with botulinum toxin type A. Luna Ortiz K, Rascon Ortiz M, Sansón Riofrio JA, Villavicencio Valencia V, Mosqueda Taylor A. Med Oral Patol Oral Cir Bucal; 2007 Jan 01; 12(1):E79-84. PubMed ID: 17195837 [Abstract] [Full Text] [Related]
14. Treatment of gustatory sweating with low-dose botulinum toxin A: a case report. Bakke M, Max Thorsen N, Bardow A, Dalager T, Eckhart Thomsen C, Regeur L. Acta Odontol Scand; 2006 Jun 01; 64(3):129-33. PubMed ID: 16809188 [Abstract] [Full Text] [Related]
15. Botulinum toxin type A for Frey's syndrome: a preliminary prospective study. Laccourreye O, Muscatelo L, Naude C, Bonan B, Brasnu D. Ann Otol Rhinol Laryngol; 1998 Jan 01; 107(1):52-5. PubMed ID: 9439389 [Abstract] [Full Text] [Related]
16. [Treatment of Frey's syndrome using botulinum toxin]. Bachmann-Harildstad G, Wenus S, Vik O. Tidsskr Nor Laegeforen; 2005 Oct 06; 125(19):2624-6. PubMed ID: 16215605 [Abstract] [Full Text] [Related]
17. [Diagnostic image (147) A man with gustatory sweating. Frey's syndrome]. van den Hoogen FJ, Marres HA. Ned Tijdschr Geneeskd; 2003 Jul 12; 147(28):1356. PubMed ID: 12892011 [Abstract] [Full Text] [Related]
18. The incidence of Frey's syndrome. Rustemeyer J, Eufinger H, Bremerich A. J Craniomaxillofac Surg; 2008 Jan 12; 36(1):34-7. PubMed ID: 18023355 [Abstract] [Full Text] [Related]
19. The use of acellular dermis in the prevention of Frey's syndrome. Govindaraj S, Cohen M, Genden EM, Costantino PD, Urken ML. Laryngoscope; 2001 Nov 12; 111(11 Pt 1):1993-8. PubMed ID: 11801985 [Abstract] [Full Text] [Related]
20. Management of Frey syndrome. de Bree R, van der Waal I, Leemans CR. Head Neck; 2007 Aug 12; 29(8):773-8. PubMed ID: 17230557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]